Abivax is a publicly traded company trading on NASDAQ, led by CEO Marc de Garidel.
Upcoming earnings announcement for Abivax
Past 4 earnings reports for Abivax
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Aug 11, 2025 | H1 2025 | —Est: -$0.90 | — | —Est: $1.4M | — | — |
| Mar 24, 2025 | FY 2024 | -$2.99 | — | $13.3M | — | — |
| Sep 9, 2024 | H1 2024 | -$1.41 | — | $7.4M | — | — |
| Apr 2, 2024 | FY 2023 | -$3.71Est: -$2.38 | -55.9% | $5.0MEst: $4.8M | +5.0% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.